BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 25868132)

  • 1. Analysis of dibenzo[def,p]chrysene-deoxyadenosine adducts in wild-type and cytochrome P450 1b1 knockout mice using stable-isotope dilution UHPLC-MS/MS.
    Harper TA; Morré J; Lauer FT; McQuistan TJ; Hummel JM; Burchiel SW; Williams DE
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Apr; 782():51-6. PubMed ID: 25868132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450 1b1 in polycyclic aromatic hydrocarbon (PAH)-induced skin carcinogenesis: Tumorigenicity of individual PAHs and coal-tar extract, DNA adduction and expression of select genes in the Cyp1b1 knockout mouse.
    Siddens LK; Bunde KL; Harper TA; McQuistan TJ; Löhr CV; Bramer LM; Waters KM; Tilton SC; Krueger SK; Williams DE; Baird WM
    Toxicol Appl Pharmacol; 2015 Sep; 287(2):149-160. PubMed ID: 26049101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cytochrome p4501 family members in the metabolic activation of polycyclic aromatic hydrocarbons in mouse epidermis.
    Kleiner HE; Vulimiri SV; Hatten WB; Reed MJ; Nebert DW; Jefcoate CR; DiGiovanni J
    Chem Res Toxicol; 2004 Dec; 17(12):1667-74. PubMed ID: 15606143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic activation of racemic and enantiomeric trans-8, 9-dihydroxy-8,9-dihydrodibenzo[a,l]pyrene (dibenzo[def,p]chrysene) to dibenzo[a,l]pyrene-bis-dihydrodiols by induced rat liver microsomes and a recombinant human P450 1A1 system: the role of the K-region-derived metabolic intermediates in the formation of dibenzo[a,l]pyrene-DNA adducts.
    Nesnow S; Davis C; Padgett W; George M; Lambert G; Meyers F; Allison J; Adams L; King LC
    Chem Res Toxicol; 1998 Dec; 11(12):1596-607. PubMed ID: 9860506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of benzo[a]pyrene diol epoxide DNA-adducts by stable isotope dilution liquid chromatography/tandem mass spectrometry.
    Ruan Q; Kim HY; Jiang H; Penning TM; Harvey RG; Blair IA
    Rapid Commun Mass Spectrom; 2006; 20(8):1369-80. PubMed ID: 16557497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of dibenzo[def,p]chrysene, its active metabolites, and their 13C-labeled analogues.
    Xu D; Duan Y; Blair IA; Penning TM; Harvey RG
    Org Lett; 2008 Mar; 10(6):1059-62. PubMed ID: 18284245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dibenzo[def,p]chrysene transplacental carcinogenesis in wild-type, Cyp1b1 knockout, and CYP1B1 humanized mice.
    Madeen EP; Löhr CV; You H; Siddens LK; Krueger SK; Dashwood RH; Gonzalez FJ; Baird WM; Ho E; Bramer L; Waters KM; Williams DE
    Mol Carcinog; 2017 Jan; 56(1):163-171. PubMed ID: 26990437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and quantification of DNA adducts in the oral tissues of mice treated with the environmental carcinogen dibenzo[a,l]pyrene by HPLC-MS/MS.
    Zhang SM; Chen KM; Aliaga C; Sun YW; Lin JM; Sharma AK; Amin S; El-Bayoumy K
    Chem Res Toxicol; 2011 Aug; 24(8):1297-303. PubMed ID: 21736370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dibenzo[def,p]chrysene (DBC) suppresses antibody formation in spleen cells following oral exposures of mice.
    Lauer FT; Walker MK; Burchiel SW
    J Toxicol Environ Health A; 2013; 76(1):16-24. PubMed ID: 23151208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the genotoxicity of dibenzo[c,p]chrysene in human carcinoma MCF-7 cells in culture.
    Mahadevan B; Luch A; Atkin J; Nguyen T; Sharma AK; Amin S; Baird WM
    Chem Biol Interact; 2006 Dec; 164(3):181-91. PubMed ID: 17094953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The K-region trans-8,9-diol does not significantly contribute as an intermediate in the metabolic activation of dibenzo[a,l]pyrene to DNA-binding metabolites by human cytochrome P450 1A1 or 1B1.
    Luch A; Kishiyama S; Seidel A; Doehmer J; Greim H; Baird WM
    Cancer Res; 1999 Sep; 59(18):4603-9. PubMed ID: 10493514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycyclic aromatic hydrocarbon-inducible DNA adducts: evidence by 32P-postlabeling and use of knockout mice for Ah receptor-independent mechanisms of metabolic activation in vivo.
    Kondraganti SR; Fernandez-Salguero P; Gonzalez FJ; Ramos KS; Jiang W; Moorthy B
    Int J Cancer; 2003 Jan; 103(1):5-11. PubMed ID: 12455047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable expression of human cytochrome P450 1B1 in V79 Chinese hamster cells and metabolically catalyzed DNA adduct formation of dibenzo[a,l]pyrene.
    Luch A; Coffing SL; Tang YM; Schneider A; Soballa V; Greim H; Jefcoate CR; Seidel A; Greenlee WF; Baird WM; Doehmer J
    Chem Res Toxicol; 1998 Jun; 11(6):686-95. PubMed ID: 9625737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quantitative comparison of dibenzo[a,l]pyrene-DNA adduct formation by recombinant human cytochrome P450 microsomes.
    King LC; Adams L; Allison J; Kohan MJ; Nelson G; Desai D; Amin S; Ross JA
    Mol Carcinog; 1999 Oct; 26(2):74-82. PubMed ID: 10506751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous detection of deoxyadenosine and deoxyguanosine adducts in the tongue and other oral tissues of mice treated with Dibenzo[a,l]pyrene.
    Zhang SM; Chen KM; Sun YW; Aliaga C; Lin JM; Sharma AK; Amin S; El-Bayoumy K
    Chem Res Toxicol; 2014 Jul; 27(7):1199-206. PubMed ID: 24911113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450 1B1 determines susceptibility to dibenzo[a,l]pyrene-induced tumor formation.
    Buters JT; Mahadevan B; Quintanilla-Martinez L; Gonzalez FJ; Greim H; Baird WM; Luch A
    Chem Res Toxicol; 2002 Sep; 15(9):1127-35. PubMed ID: 12230405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional Profiling of Dibenzo[def,p]chrysene-induced Spleen Atrophy Provides Mechanistic Insights into its Immunotoxicity in MutaMouse.
    Chepelev NL; Long AS; Williams A; Kuo B; Gagné R; Kennedy DA; Phillips DH; Arlt VM; White PA; Yauk CL
    Toxicol Sci; 2016 Jan; 149(1):251-68. PubMed ID: 26496743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectral and conformational analysis of deoxyadenosine adducts derived from syn- and anti-Dibenzo[a,l]pyrene diol epoxides: fluorescence studies.
    Jankowiak R; Lin CH; Zamzow D; Roberts KP; Li KM; Small GJ
    Chem Res Toxicol; 1999 Sep; 12(9):768-77. PubMed ID: 10490497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of phytochemical intervention on dibenzo[a,l]pyrene-induced DNA adduct formation.
    Russell GK; Gupta RC; Vadhanam MV
    Mutat Res; 2015 Apr; 774():25-32. PubMed ID: 25794985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cytochrome P450 1a1 and 1b1 in the metabolic activation of 7,12-dimethylbenz[a]anthracene and the effects of naturally occurring furanocoumarins on skin tumor initiation.
    Kleiner HE; Vulimiri SV; Reed MJ; Uberecken A; DiGiovanni J
    Chem Res Toxicol; 2002 Feb; 15(2):226-35. PubMed ID: 11849049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.